Notice2022-19381
Office of the Secretary; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 8, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 173 (Thursday, September 8, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 173 (Thursday, September 8, 2022)]
[Notices]
[Pages 55011-55012]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-19381]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Muscular Dystrophy
Coordinating Committee (MDCC).
[[Page 55012]]
The meeting will be open to the public. Individuals who plan to
participate and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Date: October 3, 2022.
Time: 1:00 p.m. to 5:00 p.m. EDT.
Agenda: The purpose of this meeting is to bring together
committee members, representing government agencies, patient
advocacy groups, other voluntary health organizations, and patients
and their families to update one another on progress relevant to the
Action Plan for the Muscular Dystrophies and to coordinate
activities and discuss gaps and opportunities leading to better
understanding of the muscular dystrophies, advances in treatments,
and improvements in patients' and their families' lives. The agenda
for this meeting will be available on the MDCC website: <a href="https://www.mdcc.nih.gov/">https://www.mdcc.nih.gov/</a>.
Registration: To register, please go to: <a href="https://roseliassociates.zoomgov.com/webinar/register/WN_ZAC101DzRVy7jcFHmIIIJw">https://roseliassociates.zoomgov.com/webinar/register/WN_ZAC101DzRVy7jcFHmIIIJw</a>.
Webcast Live: <a href="https://videocast.nih.gov/">https://videocast.nih.gov/</a>.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Glen Nuckolls, Ph.D., Program Director, National
Institute of Neurological, Disorders and Stroke (NINDS), NIH, 6001
Executive Blvd., Rm 2203, Bethesda, MD 20892, 301-496-5876,
<a href="/cdn-cgi/l/email-protection#a6ebe2e5e5e6c8cfce88c1c9d0"><span class="__cf_email__" data-cfemail="b2fff6f1f1f2dcdbda9cd5ddc4">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
More information can be found on the Muscular Dystrophy
Coordinating Committee home page: <a href="https://mdcc.nih.gov/">https://mdcc.nih.gov/</a>.
Dated: September 1, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19381 Filed 9-7-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 8, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.